Bausch + Lomb Q1 revenue rises 9%, beats estimates; lifts 2026 outlook

Bausch + Lomb

29/04/2026 12:06

Overview

US eye health firm's Q1 revenue rose 9%, beating analyst expectations

Adjusted EPS for Q1 missed analyst consensus

Company raised 2026 revenue and adjusted EBITDA guidance on strong performance

Outlook

Bausch + Lomb raises 2026 revenue guidance to $5.420 bln–$5.520 bln

Company lifts 2026 adjusted EBITDA excluding acquired IPR&D guidance to $1.010 bln–$1.060 bln

Company now expects 2026 revenue constant currency growth of 5.3%–7.2%

Result Drivers

PHARMACEUTICALS GROWTH - Double-digit revenue growth in Pharmaceuticals, led by increased sales of MIEBO and XIIDRA and growth in International Pharmaceuticals

VISION CARE DEMAND - Growth in Vision Care segment driven by over-the-counter dry eye products, LUMIFY, and SiHy Daily contact lenses

OPERATING EFFICIENCIES - Improved operating income attributed to revenue growth and operational efficiencies, including broad AI adoption

Company press release: ID:nBw9qCQ77a

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Revenue
Beat
$1.24 bln
$1.22 bln (12 Analysts)
Q1 Adjusted EPS
Miss
$0.05
$0.06 (13 Analysts)
Q1 EPS
-$0.20
Q1 Adjusted Net Income
Slight Beat*
$19 mln
$18.92 mln (9 Analysts)
Q1 Net Income
-$71 mln
Q1 Adjusted EBITDA
Slight Beat*
$189 mln
$187.40 mln (11 Analysts)
Q1 Operating Income
$33 mln


*Applies to a deviation of less than 1%; not applicable for per-share numbers.

Analyst Coverage

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 4 "strong buy" or "buy", 8 "hold" and 1 "sell" or "strong sell"

The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy."

Wall Street's median 12-month price target for Bausch + Lomb Corp is $18.00, about 14.5% above its April 28 closing price of $15.72

The stock recently traded at 18 times the next 12-month earnings vs. a P/E of 22 three months ago

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)